Luis Alejandro Zúñiga

2PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Sep 19, 2022
Intratumoral delivery of TransCon™ TLR7/8 Agonist promotes sustained anti-tumor activity and local immune cell activation while minimizing systemic cytokine induction.

Luis Alejandro Zúñiga, Torben Leßmann, Karan Uppal

|Jul 11, 2022
TransCon IL-2 β/γ: a novel long-acting prodrug with sustained release of an IL-2Rβ/γ-selective IL-2 variant with improved pharmacokinetics and potent activation of cytotoxic immune cells for the treatment of cancer.

David B Rosen, Anne Månsson Kvarnhammar, Burkhardt Laufer

Pageof 1

Frequent Collaborators

2 joint publications

David B Rosen

1 joint publications

Caroline E Rasmussen

1 joint publications

Dhruv Thakar

1 joint publications

Yu-Chi Lee